Breast Cancer
Conference Coverage
ONC-CHAT: What Did You Learn this Week that Will Change the Way You Work?
Video
San Antonio Roundtable, Part 4: Everolimus in Clinical Practice, a New CDK Inhibitor
News
Late Leukemia Risk Rises after Breast Cancer Therapy
Major Finding: The 10-year incidence of leukemia after adjuvant chemotherapy for breast cancer appears to hover around 0.5%, twice as high as...
News
Genetic Vulnerabilities Identified in Residual TNBC After Neoadjuvant Chemo
Major Finding: About 90% of patients had tumors harboring genetic alterations in clinical pathways that could be potentially targeted, such as the...
Video
ONC-CHAT: What Captured Your Imagination?
Video
ONC-CHAT: 'VOGL, NEW YORK' on 10 Years of Tamoxifen
News
PET/CT Pinpoints Physiological Evidence of Chemo Brain
Major Finding: Statistically significant declines in glucose metabolism were observed post chemotherapy in the superior medial frontal gyrus as a...
News
Mammograms Dip in Wake of USPSTF Recommendations
Major Finding: Breast mammography among women on Medicare declined 4.3% in 2010, the first full year after the USPSTF recommendations came out....
Conference Coverage
Ten Years of Adjuvant Tamoxifen Found Superior to Five
Major Finding: Women randomized to 10 years of adjuvant tamoxifen had a 25% reduction in recurrences and a 29% lower mortality due to breast...
Conference Coverage
Less Invasive Biopsy Used Less in Black Breast Cancer Patients
Major Finding: From 2002 to 2007, significantly fewer black women than white women with invasive breast cancer underwent a sentinel lymph node...
Conference Coverage
Experimental Drug Puts ER-Positive Breast Cancer on Hold
Major Finding: Compared with letrozole alone, letrozole plus PD 0332991 was associated with significantly better progression-free survival (26.1...